Clear Eyes Redness Relief — Class II drug recall D-0871-2026
Ongoing recall by Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company, reported 2026-09-30, distributed nationwide. Lack of Assurance of Sterility
| Recall number | D-0871-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company, Tarrytown, NY, United States |
| Recall initiated | 2026-09-15 |
| Classified | 2026-09-23 |
| Reported by FDA | 2026-09-30 |
| Distributed | Nationwide (US) |
| Reason classes | sterility |
| NDC | 67172-0797-15 |
| Lot numbers | RL25G04, RL2H02 |
| Expiration dates | 2027-07, 2027-08 |
Product
Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with Hang Tag, 0.5 fl oz (15mL) per dropper bottle, STERILE, Dist. by Medtech Products Inc., Tarrytown, NY 10591. NDC: 67172-797-15
Reason for recall
Lack of Assurance of Sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0871-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-10-06. Not affiliated with or endorsed by FDA. Not medical or legal advice.